Abbott Laboratories
ABT
$135.08
-$2.63-1.91%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.97B | 7.79B | 7.22B | 6.65B | 7.28B |
| Total Receivables | 6.93B | 7.05B | 6.85B | 6.61B | 6.57B |
| Inventory | 6.19B | 6.81B | 6.81B | 6.83B | 6.57B |
| Prepaid Expenses | 2.18B | 2.05B | 2.02B | 2.12B | 2.09B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 390.00M | 101.00M | 210.00M | 170.00M | 169.00M |
| Total Current Assets | 23.66B | 23.80B | 23.12B | 22.38B | 22.67B |
|
|
|||||
| Total Current Assets | 23.66B | 23.80B | 23.12B | 22.38B | 22.67B |
| Net Property, Plant & Equipment | 11.73B | 10.62B | 10.23B | 10.11B | 11.28B |
| Long-term Investments | 23.11B | 23.66B | 23.31B | 23.38B | 23.68B |
| Goodwill | 23.11B | 23.66B | 23.31B | 23.38B | 23.68B |
| Total Other Intangibles | 6.65B | 7.35B | 7.83B | 8.30B | 8.82B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.70B | 8.33B | 7.96B | 7.80B | 6.29B |
| Total Assets | 81.41B | 74.36B | 73.02B | 72.47B | 73.21B |
|
|
|||||
| Total Accounts Payable | 4.20B | 4.03B | 4.13B | 4.18B | 4.30B |
| Total Accrued Expenses | 6.46B | 6.77B | 6.39B | 6.18B | 6.54B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.75B | 2.17B | 1.63B | 2.04B | 1.33B |
| Total Finance Division Other Current Liabilities | 1.75B | 1.93B | 1.62B | 1.62B | 1.68B |
| Total Other Current Liabilities | 1.75B | 1.93B | 1.62B | 1.62B | 1.68B |
| Total Current Liabilities | 14.16B | 14.90B | 13.76B | 14.02B | 13.84B |
|
|
|||||
| Total Current Liabilities | 14.16B | 14.90B | 13.76B | 14.02B | 13.84B |
| Long-Term Debt | 12.63B | 12.88B | 13.21B | 12.66B | 13.60B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 896.00M | -- | -- | -- | 949.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.84B | 6.55B | 6.48B | 6.74B | 6.00B |
| Total Liabilities | 33.51B | 34.33B | 33.46B | 33.42B | 34.39B |
|
|
|||||
| Common Stock & APIC | 25.15B | 25.02B | 24.86B | 24.73B | 24.87B |
| Retained Earnings | 47.26B | 39.06B | 38.35B | 38.01B | 37.55B |
| Treasury Stock & Other | -24.75B | -24.28B | -23.89B | -23.93B | -23.82B |
| Total Common Equity | 47.66B | 39.80B | 39.32B | 38.81B | 38.60B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 47.66B | 39.80B | 39.32B | 38.81B | 38.60B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 237.00M | 232.00M | 242.00M | 233.00M | 224.00M |
| Total Equity | 47.90B | 40.03B | 39.56B | 39.04B | 38.83B |
|
|
|||||
